Agilent Technologies Opens New X-ray Diffraction Manufacturing Facility
News Nov 21, 2012
The new site has been designed specifically for the production of Agilent's expanding range of products for single-crystal X-ray diffraction, including the recently launched GV1000 X-ray Diffractometer.
"We have been looking forward to relocating to a larger, custom-designed facility for some time," said Zdzislaw Bober, country manager for Agilent Poland. "The building provides enhanced facilities for product development and manufacturing, and also provides a greatly enhanced working environment for all local employees. The space has been designed to comply with the strictest X-ray safety requirements, and this enables us to work more easily with higher intensity X-ray equipment."
Single-crystal X-ray diffraction systems are used for routine analytical chemistry and challenging small molecule and protein diffraction studies. The new facility is located only a few kilometers from Agilent's previous Wroclaw location, which the business has been steadily outgrowing as part of the Varian acquisition in 2010.
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE
Large-Scale Production of Living Brain Cells Enables Entirely New ResearchNews
After performing a biopsy on the patient, the skin cells are transformed into brain cells that effectively imitate the disease and the age of the patient.READ MORE
U.S. Study of Dapivirine Ring in Lactating Women Finds Little Drug Gets Into Breast MilkNews
The antiretroviral drug dapivirine that is released from an experimental vaginal ring to protect against HIV is absorbed in very low concentrations into breastmilk.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018